S2-E46.3 - Top Stories From Paris NASH: Connecting the Dots
Send us a text Jörn Schattenberg joins Stephen Harrison and Roger Green to review some highlights from last week's Paris NASH meeting. This conversation looks at the Day Two sessions and the overall implications of the meeting. Paris NASH is a meeting for basic science and interdisciplinary thinking. While the first two conversations of this series focused specifically on one or two sessions, this one takes a broader view and searches for high-level lessons and questions. From the second day,...
19 Sep 202114min
S2-E46.1 - Top stories from Paris NASH: Epidemiology and Clinical Aspects
Send us a text Jörn Schattenberg joins Stephen Harrison and Roger Green to review some highlights from last week's Paris NASH meeting. This conversation looks at sessions covering epidemiology, public response and clinical questions. Paris NASH is a meeting for basic science and interdisciplinary thinking. As Jörn Schattenberg reviews the first two sessions of the meeting, he covers both these territories. The first session started with Professor Jeffrey Lazarus discussing some of the same is...
18 Sep 202113min
S2-E46.2 - Top Stories From Paris NASH: Deep Dive into Fibrosis
Send us a text Jörn Schattenberg joins Stephen Harrison and Roger Green to review some highlights from last week's Paris NASH meeting. This conversation looks at the session covering fibrosis. Paris NASH is a meeting for basic science and interdisciplinary thinking. Since Stephen Harrison was drafted into co-chairing the session titled "Deep Dive into Fibrosis," he led this conversation. The session included three presentations with a powerful collective message about stellate cells: that dif...
18 Sep 202112min
S2-E46 - Highlights from Paris NASH
Send us a text Jörn Schattenberg joins Stephen Harrison and Roger Green to review some highlights from last week's Paris NASH meeting, an event with exciting scientific messages and insights. If you missed last week's Paris NASH meeting, you missed some exciting presentations featuring fresh, pivotal insights about Fatty Liver diseases and some new approaches to learning about this disease. Jörn Schattenberg and Stephen Harrison combine to provide a robust synopsis of the meeting while Roger ...
16 Sep 202148min
S2-E45.3 - Discussing the EASL Guidelines and the Path to A Non-Invasive Testing Future with Donna Cryer
Send us a text Global Liver Institute President and CEO Donna Cryer joins Roger Green to discuss why recent EASL guidelines around use of non-invasive tests (NITs) in Fatty Liver diagnosis and disease tracking is such an important step for patients and treaters alike. To Global Liver Institute President and CEO Donna Cryer, the recent EASL Guidelines on use of non-invasive testing (NITs) represent a major breakthrough in GLI's ongoing "Beyond the Biopsy" campaign. In this one-on-one int...
12 Sep 202125min
S2-E45.2 - Discussing Non-Invasive Testing and the Patient Experience with Wayne Eskridge.
Send us a text Fatty Liver Foundation President Wayne Eskridge joins Louise Campbell and Roger Green to discuss why he is so enthusiastic about the FDA's recent approval of the ELF test as a prognostic test for cirrhosis. To Fatty Liver Foundation President Wayne Eskridge, FDA's recent approval of Siemens's ELF test as prognostic for cirrhosis is only the first step in the process of placing non-invasive tests (NITs) at the heart of all Fatty Liver Disease diagnosis, classification and ...
11 Sep 202126min
S2-E45.1 - Discussing Fatty Liver Disease Prevalence And Patient Awareness With Anthony Villiotti
Send us a text NASH kNOWledge President Anthony Villiotti joins Louise Campbell and Roger Green to highlight two recent publications about NAFLD/NASH prevalence (underestimated!) and patient awareness (miniscule!) and what that portends for the future, To NASH kNOWledge President Anthony Villiotti, two recent publications reveal that conventional estimates of NAFLD and NASH prevalence in the US may be as much as 50% too low and, simultaneously, that very few patients are aware they have...
11 Sep 202129min
S2-E45 - Ask the Advocates: The Biggest NAFLD/NASH Story of the Summer
Send us a text Louise Campbell and Roger Green interview patients/patient advocates Donna Cryer, Wayne Eskridge and Anthony Villiotti about what each considers the biggest NAFLD story of the summer. The Biggest NAFLD/NASH story of the summer? Each had different ideas. To NASH kNOWledge President and Founder Tony Villiotti, the biggest story combined two recent publications that cross-validated the ideas that NAFLD and NASH incidence in the US maybe be 50% higher than is conventionally estimat...
9 Sep 20211h 15min
